{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:03:39Z","timestamp":1780722219747,"version":"3.54.1"},"reference-count":106,"publisher":"Bentham Science Publishers Ltd.","issue":"19","funder":[{"DOI":"10.13039\/501100004748","name":"Research Council of Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["8989081"],"award-info":[{"award-number":["8989081"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Neurodegenerative procedures include a large spectrum of disorders with\ndiverse pathological features and clinical manifestations, such as Alzheimer's Disease (AD), Parkinson's\ndisease (PD), Multiple sclerosis, and Amyotrophic lateral sclerosis (ALS). Neurodegenerative\ndiseases (NDs) are indicated by progressive loss of neurons and cognitive function, which is associated\nwith free radical formation, extra and intercellular accumulation of misfolded proteins, oxidative\nstress, mitochondrial and neurotrophins dysfunction, bioenergetic impairment, inflammation,\nand apoptotic cell death. Boswellic acid is a pentacyclic triterpene molecule of plant origin that has\nbeen applied for treating several inflammatory disorders. Numerous studies have also investigated\nits\u2019 therapeutic potential against multiple NDs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this article, we aim to review the neuroprotective effects of boswellic acid on NDs and\nthe related mechanisms of action.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The databases of PubMed, Google Scholar, Web of Sciences, and Scopus were searched\nto find studies that reported the effects of boswellic acid on NDs without time limits. Review articles,\nletters, editorials, unpublished data, and articles not published in the English language were not\nincluded in the study.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Overall, 17 studies were included in the present study (8 NDs in general, 5 AD, 3 PD, and\n1 ALS). According to the reports, boswellic acid exerts anti-inflammatory, antioxidant, antiapoptotic,\nand neuromodulatory effects against NDs. Boswellic acid decreases Tau phosphorylation\nand amyloid-\u03b2 (A\u03b2) generation in AD. This substance also protects nigrostriatal dopaminergic neurons\nand improves motor impairments in PD and modulates neurotransmitters, decreases the demyelination\nregion, and improves behavioral functions in ALS.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Due to the significant effects of boswellic acid in NDs, more clinical studies are necessary\nto evaluate the pharmacokinetics of this substance because it seems that boswellic acid can be\nused as a complementary or alternative treatment in patients with NDs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>PROSPERO Registration Number:<\/jats:title>\n<jats:p>361020.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557523666230330113611","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:58:20Z","timestamp":1680235100000},"page":"1912-1925","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Molecular Targets Underlying the Neuroprotective Effects of Boswellic\nAcid: A Systematic Review"],"prefix":"10.2174","volume":"23","author":[{"given":"Faezeh","family":"Khaafi","sequence":"first","affiliation":[{"name":"Department of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8512-3215","authenticated-orcid":true,"given":"Behjat","family":"Javadi","sequence":"additional","affiliation":[{"name":"Department of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Hou Y.","year":"2019","unstructured":"Hou Y.; Dan X.; Babbar M.; Wei Y.; Hasselbalch S.G.; Croteau D.L.; Bohr V.A.; Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 2019,15(10),565-581","journal-title":"Nat Rev Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JAD-190204","volume":"71","author":"Maher B.A.","year":"2019","unstructured":"Maher B.A.; Airborne magnetite-and iron-rich pollution nanoparticles: Potential neurotoxicants and environmental risk factors for neurodegenerative disease, including Alzheimer\u2019s disease. J Alzheimers Dis 2019,71(2),361-375","journal-title":"J Alzheimers Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/JAMMR\/2018\/40072","volume":"25","author":"Whiteside M.","year":"2018","unstructured":"Whiteside M.; Herndon J.; Aerosolized coal fly ash: Risk factor for neurodegenerative disease. J Adv Med Med Res 2018,25(10),1-11","journal-title":"J Adv Med Med Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1080\/1028415X.2019.1681088","volume":"24","author":"Bianchi V.E.","year":"2021","unstructured":"Bianchi V.E.; Herrera P.F.; Laura R.; Effect of nutrition on neurodegenerative diseases. A systematic review. Nutr Neurosci 2021,24(10),810-834","journal-title":"Nutr Neurosci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1590\/2446-4740.00118","volume":"34","author":"Elias L.A.","year":"2018","unstructured":"Elias L.A.; Matoso D.E.C.; Watanabe R.N.; Kohn A.F.; Perspectives on the modeling of the neuromusculoskeletal system to investigate the influence of neurodegenerative diseases on sensorimotor control. Res Biomed Eng 2018,34(2),176-186","journal-title":"Res Biomed Eng"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1093\/brain\/awaa218","volume":"143","author":"S\u00e4rk\u00e4m\u00f6 T.","year":"2020","unstructured":"S\u00e4rk\u00e4m\u00f6 T.; Sihvonen A.J.; Lost in sound: Auditory perceptual abilities in neurodegenerative diseases. Brain 2020,143(9),2626-2627","journal-title":"Brain"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fnins.2020.00213","volume":"14","author":"Muddapu V.R.","year":"2020","unstructured":"Muddapu V.R.; Dharshini S.A.P.; Chakravarthy V.S.; Gromiha M.M.; Neurodegenerative diseases\u2013is metabolic deficiency the root cause? Front Neurosci 2020,14,213","journal-title":"Front Neurosci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.abb8032","volume":"370","author":"Mathieu C.","year":"2020","unstructured":"Mathieu C.; Pappu R.V.; Taylor J.P.; Beyond aggregation: Pathological phase transitions in neurodegenerative disease. Science 2020,370(6512),56-60","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mito.2018.11.002","volume":"47","author":"Panchal K.","year":"2019","unstructured":"Panchal K.; Tiwari A.K.; Mitochondrial dynamics, a key executioner in neurodegenerative diseases. Mitochondrion 2019,47,151-173","journal-title":"Mitochondrion"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.2174\/1381612825666190115121018","volume":"24","author":"Wadhwa R.","year":"2019","unstructured":"Wadhwa R.; Gupta R.; Maurya P.K.; Oxidative stress and accelerated aging in neurodegenerative and neuropsychiatric disorder. Curr Pharm Des 2019,24(40),4711-4725","journal-title":"Curr Pharm Des"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/1873-3468.12956","volume":"592","author":"Nissanka N.","year":"2018","unstructured":"Nissanka N.; Moraes C.T.; Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease. FEBS Lett 2018,592(5),728-742","journal-title":"FEBS Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.3390\/ijms20102407","volume":"20","author":"Collin F.","year":"2019","unstructured":"Collin F.; Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int J Mol Sci 2019,20(10),2407","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","volume":"154","author":"Stephenson J.","year":"2018","unstructured":"Stephenson J.; Nutma E.; van der Valk P.; Amor S.; Inflammation in CNS neurodegenerative diseases. Immunology 2018,154(2),204-219","journal-title":"Immunology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/antiox9080743","volume":"9","author":"Simpson D.S.A.","year":"2020","unstructured":"Simpson D.S.A.; Oliver P.L.; ROS generation in microglia: Understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants 2020,9(8),743","journal-title":"Antioxidants"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12906-018-2160-6","volume":"18","author":"Welz A.N.","year":"2018","unstructured":"Welz A.N.; Emberger-Klein A.; Menrad K.; Why people use herbal medicine: Insights from a focus-group study in Germany. BMC Complement Altern Med 2018,18(1),92","journal-title":"BMC Complement Altern Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"105056","DOI":"10.1016\/j.phrs.2020.105056","volume":"160","author":"Xiong X.","year":"2020","unstructured":"Xiong X.; Wang P.; Su K.; Cho W.C.; Xing Y.; Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis. Pharmacol Res 2020,160,105056","journal-title":"Pharmacol Res"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.2174\/1389557522666220523112027","author":"Ghaderi M.A.","year":"2022","unstructured":"Ghaderi M.A.; Emam S.A.; Javadi B.; The role of sesamin in targeting the neurodegenerative disorders: A systematic review. Mini Rev Med Chem 2022","journal-title":"Mini Rev Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.3390\/ijms20174101","volume":"20","author":"Roy N.K.","year":"2019","unstructured":"Roy N.K.; Parama D.; Banik K.; Bordoloi D.; Devi A.K.; Thakur K.K.; Padmavathi G.; Shakibaei M.; Fan L.; Sethi G.; Kunnumakkara A.B.; An update on pharmacological potential of boswellic acids against chronic diseases. Int J Mol Sci 2019,20(17),4101","journal-title":"Int J Mol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2174\/1381612822666161021143332","volume":"23","author":"Javadi B.","year":"2017","unstructured":"Javadi B.; Sahebkar A.; Emami S.A.; Medicinal plants for the treatment of asthma: A traditional persian medicine perspective. Curr Pharm Des 2017,23(11),1623-1632","journal-title":"Curr Pharm Des"},{"key":"ref=20","first-page":"468","volume":"6","author":"Beheshti S.","year":"2016","unstructured":"Beheshti S.; Aghaie R.; Therapeutic effect of frankincense in a rat model of Alzheimer\u2019s disease. Avicenna J Phytomed 2016,6(4),468-475","journal-title":"Avicenna J Phytomed"},{"key":"ref=21","author":"Mehta M.","year":"2018","unstructured":"Mehta M.; Shukla B.; Khurana N.; Arora P.; Sharma N.; Mahajan S.;  Recent patent technologies of boswellic acids: A short review 2018","journal-title":"Recent patent technologies of boswellic acids: A short review"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"108656","DOI":"10.1016\/j.abb.2020.108656","volume":"695","author":"Karra A.G.","year":"2020","unstructured":"Karra A.G.; Tziortziou, M.; Kylindri, P.; Georgatza, D.; Gorgogietas, V.A.; Makiou, A.; Krokida, A.; Tsialtas, I.; Kalousi, F.D.; Papadopoulos, G.E.; Papadopoulou, K.and#922.; Psarra, A.M.G. Boswellic acids and their derivatives as potent regulators of glucocorticoid receptor actions. Arch Biochem Biophys 2020,695,108656","journal-title":"Arch Biochem Biophys"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12906-017-2062-z","volume":"18","author":"Haroyan A.","year":"2018","unstructured":"Haroyan A.; Mukuchyan V.; Mkrtchyan N.; Minasyan N.; Gasparyan S.; Sargsyan A.; Narimanyan M.; Hovhannisyan A.; Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: A comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med 2018,18(1),7","journal-title":"BMC Complement Altern Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"114106","DOI":"10.1016\/j.jpba.2021.114106","volume":"201","author":"Zwerger M.","year":"2021","unstructured":"Zwerger M.; Ganzera M.; Analysis of boswellic acids in dietary supplements containing Indian frankincense (Boswellia serrata) by Supercritical Fluid Chromatography. J Pharm Biomed Anal 2021,201,114106","journal-title":"J Pharm Biomed Anal"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10787-022-00939-7","volume":"30","author":"Gomaa A.A.","year":"2022","unstructured":"Gomaa A.A.; Mohamed H.S.; Abd-ellatief R.B.; Gomaa M.A.; Hammam D.S.; Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: A randomized clinical trial. Inflammopharmacology 2022,30(2),477-486","journal-title":"Inflammopharmacology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijbiomac.2020.03.073","volume":"154","author":"Narasagoudr S.S.","year":"2020","unstructured":"Narasagoudr S.S.; Hegde V.G.; Chougale R.B.; Masti S.P.; Dixit S.; Influence of boswellic acid on multifunctional properties of chitosan\/poly (vinyl alcohol) films for active food packaging. Int J Biol Macromol 2020,154,48-61","journal-title":"Int J Biol Macromol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.34172\/PS.2020.25","volume":"27","author":"Haghaei H.","year":"2020","unstructured":"Haghaei H.; Soltani S.; Aref Hosseini S.; Rashidi M.R.; Karima S.; Boswellic acids as promising leads in drug development against Alzheimer\u2019s disease. Ulum-i Daruyi 2020,27(1),14-31","journal-title":"Ulum-i Daruyi"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/1440-1681.13567","volume":"48","author":"Gunasekaran V.","year":"2021","unstructured":"Gunasekaran V.; Augustine A.; Avarachan J.; Khayum A.; Ramasamy A.; 3-O-Acetyl-11-keto-and#946;-boswellic acid ameliorates chronic unpredictable mild stress induced HPA axis dysregulation in relation with glutamate\/GABA aberration in depressive rats. Clin Exp Pharmacol Physiol 2021,48(12),1633-1641","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8296451","volume":"2018","author":"Barakat B.M.","year":"2018","unstructured":"Barakat B.M.; Ahmed H.I.; Bahr H.I.; Elbahaie A.M.; Protective effect of boswellic acids against doxorubicin-induced hepatotoxicity: Impact on Nrf2\/HO-1 defense pathway. Oxid Med Cell Longev 2018,2018,1-10","journal-title":"Oxid Med Cell Longev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12640-022-00628-x","volume":"41","author":"Kundu S.","year":"2023","unstructured":"Kundu S.; Singh S.; Protective Mechanisms of 3-Acetyl-11-keto-beta-boswellic acid and piperine in fluid percussion rat model of traumatic brain injury targeting Nrf2 and NFkB Signaling NeurotoxRes 2023,41(1),57-84","journal-title":"NeurotoxRes"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"112250","DOI":"10.1016\/j.biopha.2021.112250","volume":"144","author":"Siddiqui A.","year":"2021","unstructured":"Siddiqui A.; Shah Z.; Jahan R.N.; Othman I.; Kumari Y.; Mechanistic role of boswellic acids in Alzheimer\u2019s disease: Emphasis on anti-inflammatory properties. Biomed Pharmacother 2021,144,112250","journal-title":"Biomed Pharmacother"},{"key":"ref=32","first-page":"94","volume":"1","author":"Kilkenny C.","year":"2010","unstructured":"Kilkenny C.; Browne W.J.; Cuthill I.C.; Emerson M.; Altman D.G.; Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol 2010,1(2),94-99","journal-title":"PLoS Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.14573\/altex.2102261","volume":"38","author":"Ulrey A.","year":"2021","unstructured":"Ulrey A.; Kolle S.; Landsiedel R.; Hill E.; How a GIVIMP certification program can increase confidence in in vitro methods. Altern Anim Exp 2021,38(2),316-318","journal-title":"Altern Anim Exp"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","volume":"57","author":"Monzio Compagnoni G.","year":"2020","unstructured":"Monzio Compagnoni G.; Di Fonzo A.; Corti S.; Comi G.P.; Bresolin N.; Masliah E.; The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease. Mol Neurobiol 2020,57(7),2959-2980","journal-title":"Mol Neurobiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1908483","volume":"381","author":"Mackay D.F.","year":"2019","unstructured":"Mackay D.F.; Russell E.R.; Stewart K.; MacLean J.A.; Pell J.P.; Stewart W.; Neurodegenerative disease mortality among former professional soccer players. N Engl J Med 2019,381(19),1801-1808","journal-title":"N Engl J Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41582-019-0157-5","volume":"15","author":"Nedelsky N.B.","year":"2019","unstructured":"Nedelsky N.B.; Taylor J.P.; Bridging biophysics and neurology: Aberrant phase transitions in neurodegenerative disease. Nat Rev Neurol 2019,15(5),272-286","journal-title":"Nat Rev Neurol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"Singh A.","year":"2019","unstructured":"Singh A.; Kukreti R.; Saso L.; Kukreti S.; Oxidative stress: A key modulator in neurodegenerative diseases. Molecules 2019,24(8),1583","journal-title":"Molecules"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2105607","volume":"2019","author":"Cenini G.","year":"2019","unstructured":"Cenini G.; Lloret A.; Cascella R.; Oxidative stress in neurodegenerative diseases: From a mitochondrial point of view. Oxid Med Cell Longev 2019,2019,1-18","journal-title":"Oxid Med Cell Longev"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12325-019-01148-5","volume":"37","author":"Rekatsina M.","year":"2020","unstructured":"Rekatsina M.; Paladini A.; Piroli A.; Zis P.; Pergolizzi J.V.; Varrassi G.; Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: A narrative review. Adv Ther 2020,37(1),113-139","journal-title":"Adv Ther"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cca.2018.06.031","volume":"485","author":"Chang K.H.","year":"2018","unstructured":"Chang K.H.; Cheng M.L.; Chiang M.C.; Chen C.M.; Lipophilic antioxidants in neurodegenerative diseases. Clin Chim Acta 2018,485,79-87","journal-title":"Clin Chim Acta"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3233\/JAD-201186","volume":"79","author":"Clark I.A.","year":"2021","unstructured":"Clark I.A.; Vissel B.; Broader insights into understanding tumor necrosis factor and neurodegenerative disease pathogenesis infer new therapeutic approaches. J Alzheimers Dis 2021,79(3),931-948","journal-title":"J Alzheimers Dis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/14737175.2021.1907182","volume":"21","author":"McCarty M.F.","year":"2021","unstructured":"McCarty M.F.; Lerner A.; The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation. Expert Rev Neurother 2021,21(5),559-570","journal-title":"Expert Rev Neurother"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","volume":"43","author":"Lin M.","year":"2022","unstructured":"Lin M.; Liu N.; Qin Z.; Wang Y.; Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin 2022,43(10),2439-2447","journal-title":"Acta Pharmacol Sin"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"113247","DOI":"10.1016\/j.expneurol.2020.113247","volume":"328","author":"Goodfellow M.J.","year":"2020","unstructured":"Goodfellow M.J.; Borcar A.; Proctor J.L.; Greco T.; Rosenthal R.E.; Fiskum G.; Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration. Exp Neurol 2020,328,113247","journal-title":"Exp Neurol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fphar.2018.00462","volume":"9","author":"Lim H.S.","year":"2018","unstructured":"Lim H.S.; Kim Y.J.; Kim B.Y.; Park G.; Jeong S.J.; The anti-neuroinflammatory activity of tectorigenin pretreatment via downregulated NF-and#954;B and ERK\/JNK pathways in BV-2 microglial and microglia inactivation in mice with lipopolysaccharide. Front Pharmacol 2018,9,462","journal-title":"Front Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"Singh S.","year":"2020","unstructured":"Singh S.; Singh T.G.; Role of nuclear factor kappa B (NF-and#954;B) signalling in neurodegenerative diseases: An mechanistic approach. Curr Neuropharmacol 2020,18(10),918-935","journal-title":"Curr Neuropharmacol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.patter.2021.100433","volume":"3","author":"Lage-Rupprecht V.","year":"2022","unstructured":"Lage-Rupprecht V.; Schultz B.; Dick J.; Namysl M.; Zaliani A.; Gebel S.; Pless O.; Reinshagen J.; Ellinger B.; Ebeling C.; Esser A.; Jacobs M.; Claussen C.; Hofmann-Apitius M.; A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism. Patterns 2022,3(3),100433","journal-title":"Patterns"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","volume":"18","author":"Arranz A.M.","year":"2019","unstructured":"Arranz A.M.; De Strooper B.; The role of astroglia in Alzheimer\u2019s disease: Pathophysiology and clinical implications. Lancet Neurol 2019,18(4),406-414","journal-title":"Lancet Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s12031-020-01747-w","volume":"71","author":"Olajide O.J.","year":"2021","unstructured":"Olajide O.J.; Gbadamosi I.T.; Yawson E.O.; Arogundade T.; Lewu F.S.; Ogunrinola K.Y.; Adigun O.O.; Bamisi O.; Lambe E.; Arietarhire L.O.; Oluyomi O.O.; Idowu O.K.; Kareem R.; Asogwa N.T.; Adeniyi P.A.; Hippocampal degeneration and behavioral impairment during alzheimer-like pathogenesis involves glutamate excitotoxicity. J Mol Neurosci 2021,71(6),1205-1220","journal-title":"J Mol Neurosci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13195-019-0501-4","volume":"11","author":"Siedlecki-Wullich D.","year":"2019","unstructured":"Siedlecki-Wullich D.; Catal\u00e0-Solsona J.; F\u00e1bregas C.; Hern\u00e1ndez I.; Clarimon J.; Lle\u00f3 A.; Boada M.; Saura C.A.; Rodr\u00edguez-\u00c1lvarez J.; Mi\u00f1ano-Molina A.J.; Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer\u2019s disease. Alzheimers Res Ther 2019,11(1),46","journal-title":"Alzheimers Res Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41593-020-00728-x","volume":"23","author":"Richetin K.","year":"2020","unstructured":"Richetin K.; Steullet P.; Pachoud M.; Perbet R.; Parietti E.; Maheswaran M.; Eddarkaoui S.; B\u00e9gard S.; Pythoud C.; Rey M.; Caillierez R.Q.; Do K.; Halliez S.; Bezzi P.; Bu\u00e9e L.; Leuba G.; Colin M.; Toni N.; D\u00e9glon N.; Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer\u2019s disease. Nat Neurosci 2020,23(12),1567-1579","journal-title":"Nat Neurosci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"116969","DOI":"10.1016\/j.lfs.2019.116969","volume":"238","author":"Hamidi N.","year":"2019","unstructured":"Hamidi N.; Nozad A.; Sheikhkanloui Milan H.; Salari A.A.; Amani M.; Effect of ceftriaxone on paired-pulse response and long-term potentiation of hippocampal dentate gyrus neurons in rats with Alzheimer-like disease. Life Sci 2019,238,116969","journal-title":"Life Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3233\/JAD-171133","volume":"62","author":"Gosztyla M.L.","year":"2018","unstructured":"Gosztyla M.L.; Brothers H.M.; Robinson S.R.; Alzheimer\u2019s amyloid-and#946; is an antimicrobial peptide: A review of the evidence. J Alzheimers Dis 2018,62(4),1495-1506","journal-title":"J Alzheimers Dis"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"12883","DOI":"10.1039\/C8CC07921H","volume":"54","author":"Sahoo B.R.","year":"2018","unstructured":"Sahoo B.R.; Genjo T.; Bekier M.; Cox S.J.; Stoddard A.K.; Ivanova M.; Yasuhara K.; Fierke C.A.; Wang Y.; Ramamoorthy A.; Alzheimer\u2019s amyloid-beta intermediates generated using polymer-nanodiscs. Chem Commun (Camb) 2018,54(91),12883-12886","journal-title":"Chem Commun (Camb)"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.2174\/1381612825666191011102444","volume":"25","author":"Kabir M.T.","year":"2019","unstructured":"Kabir M.T.; Sufian M.A.; Uddin M.S.; Begum M.M.; Akhter S.; Islam A.; Mathew B.; Islam M.S.; Amran M.S.; Md Ashraf G.; NMDA receptor antagonists: Repositioning of memantine as a multitargeting agent for Alzheimer\u2019s therapy. Curr Pharm Des 2019,25(33),3506-3518","journal-title":"Curr Pharm Des"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1007\/s12035-021-02311-2","volume":"58","author":"Zhang L.","year":"2021","unstructured":"Zhang L.; Qi Z.; Li J.; Li M.; Du X.; Wang S.; Zhou G.; Xu B.; Liu W.; Xi S.; Xu Z.; Deng Y.; Roles and mechanisms of axon-guidance molecules in Alzheimer\u2019s disease. Mol Neurobiol 2021,58(7),3290-3307","journal-title":"Mol Neurobiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41419-017-0215-0","volume":"9","author":"Area-Gomez E.","year":"2018","unstructured":"Area-Gomez E.; de Groof A.; Bonilla E.; Montesinos J.; Tanji K.; Boldogh I.; Pon L.; Schon E.A.; A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease. Cell Death Dis 2018,9(3),335","journal-title":"Cell Death Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"Surmeier D.J.","year":"2018","unstructured":"Surmeier D.J.; Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 2018,285(19),3657-3668","journal-title":"FEBS J"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/jnr.24185","volume":"96","author":"Joshi N.","year":"2018","unstructured":"Joshi N.; Singh S.; Updates on immunity and inflammation in Parkinson disease pathology. J Neurosci Res 2018,96(3),379-390","journal-title":"J Neurosci Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s11033-020-05284-y","volume":"47","author":"Ramazani E.","year":"2020","unstructured":"Ramazani E.; YazdFazeli, M.; Emami, S.A.; Mohtashami, L.; Javadi, B.; Asili, J.; Tayarani-Najaran, Z. Protective effects of Cinnamomum verum, Cinnamomum cassia and cinnamaldehyde against 6-OHDA-induced apoptosis in PC12 cells. Mol Biol Rep 2020,47(4),2437-2445","journal-title":"Mol Biol Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00702-018-1876-2","volume":"125","author":"Riederer P.","year":"2018","unstructured":"Riederer P.; M\u00fcller T.; Monoamine oxidase-B inhibitors in the treatment of Parkinson\u2019s disease: Clinical\u2013pharmacological aspects. J Neural Transm (Vienna) 2018,125(11),1751-1757","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coph.2018.03.004","volume":"38","author":"Masilamoni G.J.","year":"2018","unstructured":"Masilamoni G.J.; Smith Y.; Metabotropic glutamate receptors: Targets for neuroprotective therapies in Parkinson disease. Curr Opin Pharmacol 2018,38,72-80","journal-title":"Curr Opin Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"101233","DOI":"10.1016\/j.eujim.2020.101233","volume":"41","author":"Tayarani-Najaran Z.","year":"2021","unstructured":"Tayarani-Najaran Z.; Rashidi R.; Rashedinia M.; Khoshbakht S.; Javadi B.; The protective effect of Lavandula officinalis extract on 6-hydroxydopamine-induced reactive oxygen species and apoptosis in PC12 cells. Eur J Integr Med 2021,41,101233","journal-title":"Eur J Integr Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1007\/s00018-020-03584-x","volume":"77","author":"Domingues A.V.","year":"2020","unstructured":"Domingues A.V.; Pereira I.M.; Vila\u00e7a-Faria H.; Salgado A.J.; Rodrigues A.J.; Teixeira F.G.; Glial cells in Parkinson\u2019s disease: Protective or deleterious? Cell Mol Life Sci 2020,77(24),5171-5188","journal-title":"Cell Mol Life Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"114023","DOI":"10.1016\/j.jep.2021.114023","volume":"273","author":"Tayarani-Najaran Z.","year":"2021","unstructured":"Tayarani-Najaran Z.; Hadipour E.; Seyed Mousavi S.M.; Emami S.A.; Mohtashami L.; Javadi B.; Protective effects of Lavandula stoechas L. methanol extract against 6-OHDA-induced apoptosis in PC12 cells. J Ethnopharmacol 2021,273,114023","journal-title":"J Ethnopharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"Tansey M.G.","year":"2022","unstructured":"Tansey M.G.; Wallings R.L.; Houser M.C.; Herrick M.K.; Keating C.E.; Joers V.; Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 2022,22(11),657-673","journal-title":"Nat Rev Immunol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-016-0063-3","volume":"5","author":"Chen L.","year":"2016","unstructured":"Chen L.; Mo M.; Li G.; Cen L.; Wei L.; Xiao Y.; Chen X.; Li S.; Yang X.; Qu S.; Xu P.; The biomarkers of immune dysregulation and inflammation response in Parkinson disease. Transl Neurodegener 2016,5(1),16","journal-title":"Transl Neurodegener"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ncpneuro0924","volume":"4","author":"Henchcliffe C.","year":"2008","unstructured":"Henchcliffe C.; Beal M.F.; Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008,4(11),600-609","journal-title":"Nat Clin Pract Neurol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","volume":"62","author":"Sanders L.H.","year":"2013","unstructured":"Sanders L.H.; Timothy Greenamyre J.; Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic Biol Med 2013,62,111-120","journal-title":"Free Radic Biol Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1055\/a-1502-7083","volume":"88","author":"Shasaltaneh M.D.","year":"2022","unstructured":"Shasaltaneh M.D.; Naghdi N.; Ramezani S.; Alizadeh L.; Riazi G.H.; Protection of beta boswellic acid against streptozotocin-induced Alzheimerand#700;s model by reduction of tau phosphorylation level and enhancement of reelin expression. Planta Med 2022,88(5),367-379","journal-title":"Planta Med"},{"key":"ref=71","first-page":"376","volume":"7","author":"Chen X.","year":"2012","unstructured":"Chen X.; Guo C.; Kong J.; Oxidative stress in neurodegenerative diseases. Neural Regen Res 2012,7(5),376-385","journal-title":"Neural Regen Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/jcb.29413","volume":"121","author":"Rajabian A.","year":"2020","unstructured":"Rajabian A.; Sadeghnia H.R.; Hosseini A.; Mousavi S.H.; Boroushaki M.T.; 3and#8208;Acetyland#8208;11and#8208;ketoand#8208;and#946;and#8208;boswellic acid attenuated oxidative glutamate toxicity in neuronand#8208;like cell lines by apoptosis inhibition. J Cell Biochem 2020,121(2),1778-1789","journal-title":"J Cell Biochem"},{"key":"ref=73","first-page":"911","volume":"74","author":"Sadeghnia H.R.","year":"2017","unstructured":"Sadeghnia H.R.; Arjmand F.; Ghorbani A.; Neuroprotective effect of boswellia serrata and its active constituent acetyl 11-keto-and#946;-boswellic acid against oxygen-glucose-serum deprivation-induced cell injury. Acta Pol Pharm 2017,74(3),911-920","journal-title":"Acta Pol Pharm"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3831\/KPI.2017.20.001","volume":"20","author":"Hosseinzadeh H.","year":"2017","unstructured":"Hosseinzadeh H.; Ebrahimpour S.; Fazeli M.; Mehri S.; Taherianfard M.; Boswellic acid improves cognitive function in a rat model through its antioxidant activity:-Neuroprotective effect of boswellic acid. J Pharmacopuncture 2017,20(1),10-17","journal-title":"J Pharmacopuncture"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12017-019-08569-z","volume":"21","author":"Ahmad S.","year":"2019","unstructured":"Ahmad S.; Khan S.A.; Kindelin A.; Mohseni T.; Bhatia K.; Hoda M.N.; Ducruet A.F.; Acetyl-11-keto-and#946;-boswellic acid (AKBA) attenuates oxidative stress, inflammation, complement activation and cell death in brain endothelial cells following OGD\/reperfusion. Neuromol Med 2019,21(4),505-516","journal-title":"Neuromol Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2478\/aiht-2019-70-3263","volume":"70","author":"Mohammadi H.","year":"2019","unstructured":"Mohammadi H.; Ghassemi-Barghi N.; Malakshah O.; Ashari S.; Pyrethroid exposure and neurotoxicity: A mechanistic approach. Arh Hig Rada Toksikol 2019,70(2),74-89","journal-title":"Arh Hig Rada Toksikol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s12035-014-8929-9","volume":"52","author":"Ding Y.","year":"2015","unstructured":"Ding Y.; Chen M.; Wang M.; Li Y.; Wen A.; Posttreatment with 11-keto-and#946;-boswellic acid ameliorates cerebral ischemia\u2013reperfusion injury: Nrf2\/HO-1 pathway as a potential mechanism. Mol Neurobiol 2015,52(3),1430-1439","journal-title":"Mol Neurobiol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1038\/srep07002","volume":"4","author":"Ding Y.","year":"2014","unstructured":"Ding Y.; Chen M.; Wang M.; Wang M.; Zhang T.; Park J.; Zhu Y.; Guo C.; Jia Y.; Li Y.; Wen A.; Neuroprotection by acetyl-11-keto-and#946;-Boswellic acid, in ischemic brain injury involves the Nrf2\/HO-1 defense pathway. Sci Rep 2014,4(1),7002","journal-title":"Sci Rep"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"155107","DOI":"10.1016\/j.cyto.2020.155107","volume":"131","author":"Marefati N.","year":"2020","unstructured":"Marefati N.; Beheshti F.; Memarpour S.; Bayat R.; Naser Shafei M.; Sadeghnia H.R.; Ghazavi H.; Hosseini M.; The effects of acetyl-11-keto-and#946;-boswellic acid on brain cytokines and memory impairment induced by lipopolysaccharide in rats. Cytokine 2020,131,155107","journal-title":"Cytokine"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1007\/s12035-017-0801-2","volume":"55","author":"Sayed A.S.","year":"2018","unstructured":"Sayed A.S.; Gomaa I.E.O.; Bader M.; El Sayed N.S.E.D.; Role of 3-acetyl-11-keto-beta-boswellic acid in counteracting LPS-induced neuroinflammation via modulation of miRNA-155. Mol Neurobiol 2018,55(7),5798-5808","journal-title":"Mol Neurobiol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"Long J.M.","year":"2019","unstructured":"Long J.M.; Holtzman D.M.; Alzheimer disease: An update on pathobiology and treatment strategies. Cell 2019,179(2),312-339","journal-title":"Cell"},{"key":"ref=82","first-page":"1102","volume":"22","author":"Iranshahy M.","year":"2019","unstructured":"Iranshahy M.; Javadi B.; Diet therapy for the treatment of Alzheimer\u2019s disease in view of traditional Persian medicine: A review. Iran J Basic Med Sci 2019,22(10),1102-1117","journal-title":"Iran J Basic Med Sci"},{"key":"ref=83","first-page":"1403","volume":"83","author":"Winslow B.T.","year":"2011","unstructured":"Winslow B.T.; Onysko M.K.; Stob C.M.; Hazlewood K.A.; Treatment of Alzheimer disease. Am Fam Physician 2011,83(12),1403-1412","journal-title":"Am Fam Physician"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"76135","DOI":"10.1007\/s11356-022-20611-5","volume":"29","author":"Mohamed E.A.","year":"2022","unstructured":"Mohamed E.A.; Ahmed H.I.; Zaky H.S.; Badr A.M.; Boswellic acids ameliorate neurodegeneration induced by AlCl3: The implication of Wnt\/and#946;-catenin pathway. Environ Sci Pollut Res Int 2022,29(50),76135-76143","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12017-016-8437-3","volume":"19","author":"Fathi E.","year":"2017","unstructured":"Fathi E.; Katouli F.H.; Riazi G.H.; Shasaltaneh M.D.; Parandavar E.; Bayati S.; Afrasiabi A.; Nazari R.; The effects of alpha boswellic acid on reelin expression and tau phosphorylation in human astrocytes. Neuromol Med 2017,19(1),136-146","journal-title":"Neuromol Med"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11011-020-00639-7","volume":"36","author":"Mohamed T.M.","year":"2021","unstructured":"Mohamed T.M.; Youssef M.A.M.; Bakry A.A.; El-Keiy M.M.; Alzheimer\u2019s disease improved through the activity of mitochondrial chain complexes and their gene expression in rats by boswellic acid. Metab Brain Dis 2021,36(2),255-264","journal-title":"Metab Brain Dis"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2019.00902","volume":"10","author":"Cenini G.","year":"2019","unstructured":"Cenini G.; Voos W.; Mitochondria as potential targets in Alzheimer disease therapy: An update. Front Pharmacol 2019,10,902","journal-title":"Front Pharmacol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s11064-014-1454-4","volume":"39","author":"Obulesu M.","year":"2014","unstructured":"Obulesu M.; Lakshmi M.J.; Apoptosis in Alzheimer\u2019s disease: An understanding of the physiology, pathology and therapeutic avenues. Neurochem Res 2014,39(12),2301-2312","journal-title":"Neurochem Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.freeradbiomed.2020.02.022","volume":"150","author":"Wei C.","year":"2020","unstructured":"Wei C.; Fan J.; Sun X.; Yao J.; Guo Y.; Zhou B.; Shang Y.; Acetyl-11-keto-and#946;-boswellic acid ameliorates cognitive deficits and reduces amyloid-and#946; levels in APPswe\/PS1dE9 mice through antioxidant and anti-inflammatory pathways. Free Radic Biol Med 2020,150,96-108","journal-title":"Free Radic Biol Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","volume":"40","author":"Forner S.","year":"2017","unstructured":"Forner S.; Baglietto-Vargas D.; Martini A.C.; Trujillo-Estrada L.; LaFerla F.M.; Synaptic impairment in Alzheimer\u2019s disease: A dysregulated symphony. Trends Neurosci 2017,40(6),347-357","journal-title":"Trends Neurosci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopha.2017.01.123","volume":"88","author":"Baluchnejadmojarad T.","year":"2017","unstructured":"Baluchnejadmojarad T.; Mansouri M.; Ghalami J.; Mokhtari Z.; Roghani M.; Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress. Biomed Pharmacother 2017,88,754-761","journal-title":"Biomed Pharmacother"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jcp.26865","volume":"234","author":"Hassanzadeh K.","year":"2019","unstructured":"Hassanzadeh K.; Rahimmi A.; Oxidative stress and neuroinflammation in the story of Parkinson\u2019s disease: Could targeting these pathways write a good ending? J Cell Physiol 2019,234(1),23-32","journal-title":"J Cell Physiol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1139\/cjpp-2016-0158","volume":"95","author":"Ameen A.M.","year":"2017","unstructured":"Ameen A.M.; Elkazaz A.Y.; Mohammad H.M.F.; Barakat B.M.; Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats. Can J Physiol Pharmacol 2017,95(7),819-829","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/jbm.a.37040","volume":"109","author":"Kheradmand H.","year":"2021","unstructured":"Kheradmand H.; Babaloo H.; Vojgani Y.; Mirzakhanlouei S.; Bayat N.; PCL\/gelatin scaffolds and BETAand#8208;BOSWELLIC ACID synergistically increase the efficiency of CGR8 stem cells differentiation into dopaminergic neuron: A new paradigm of Parkinson\u2019s disease cell therapy. J Biomed Mater Res A 2021,109(4),562-571","journal-title":"J Biomed Mater Res A"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neuroscience.2012.07.009","volume":"222","author":"Abasi M.","year":"2012","unstructured":"Abasi M.; Massumi M.; Riazi G.; Amini H.; The synergistic effect of beta-boswellic acid and Nurr1 overexpression on dopaminergic programming of antioxidant glutathione peroxidase-1-expressing murine embryonic stem cells. Neuroscience 2012,222,404-416","journal-title":"Neuroscience"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5021694","volume":"2020","author":"Cunha-Oliveira T.","year":"2020","unstructured":"Cunha-Oliveira T.; Montezinho L.; Mendes C.; Firuzi O.; Saso L.; Oliveira P.J.; Oxidative stress in amyotrophic lateral sclerosis: Pathophysiology and opportunities for pharmacological intervention. Oxid Med Cell Longev 2020,2020,1-29","journal-title":"Oxid Med Cell Longev"},{"key":"ref=97","first-page":"1","volume":"3","author":"Hardiman O.","year":"2017","unstructured":"Hardiman O.; Al-Chalabi A.; Chio A.; Corr E.M.; Logroscino G.; Robberecht W.; Amyotrophic lateral sclerosis. Nat Rev Dis Primers 2017,3(1),1-19","journal-title":"Nat Rev Dis Primers"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","volume":"46","author":"Minj E.","year":"2021","unstructured":"Minj E.; Upadhayay S.; Mehan S.; Nrf2\/HO-1 signaling activator acetyl-11-keto-beta Boswellic acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-induced experimental model of ALS. Neurochem Res 2021,46(11),2867-2884","journal-title":"Neurochem Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0378-8741(93)90005-P","volume":"38","author":"Ammon H.P.T.","year":"1993","unstructured":"Ammon H.P.T.; Safayhi H.; Mack T.; Sabieraj J.; Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 1993,38(2-3),105-112","journal-title":"J Ethnopharmacol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1515\/znc-2003-7-811","volume":"58","author":"Badria F.A.","year":"2003","unstructured":"Badria F.A.; Mikhaeil B.R.; Maatooq G.T.; Amer M.M.A.; Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood. Z Naturforsch C J Biosci 2003,58(7-8),505-516","journal-title":"Z Naturforsch C J Biosci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/s-2006-960074","volume":"57","author":"Ammon H.P.T.","year":"1991","unstructured":"Ammon H.P.T.; Mack T.; Singh G.; Safayhi H.; Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med 1991,57(3),203-207","journal-title":"Planta Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13318-019-00599-z","volume":"45","author":"Sharma T.","year":"2020","unstructured":"Sharma T.; Jana S.; Investigation of molecular properties that influence the permeability and oral bioavailability of major and#946;-boswellic acids. Eur J Drug Metab Pharmacokinet 2020,45(2),243-255","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.nut.2018.03.055","volume":"54","author":"Khayyal M.T.","year":"2018","unstructured":"Khayyal M.T.; El-Hazek R.M.; El-Sabbagh W.A.; Frank J.; Behnam D.; Abdel-Tawab M.; Micellar solubilisation enhances the antiinflammatory activities of curcumin and boswellic acids in rats with adjuvant-induced arthritis. Nutrition 2018,54,189-196","journal-title":"Nutrition"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.fitote.2012.10.009","volume":"84","author":"Gerbeth K.","year":"2013","unstructured":"Gerbeth K.; H\u00fcsch J.; Fricker G.; Werz O.; Schubert-Zsilavecz M.; Abdel-Tawab M.; In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia 2013,84,99-106","journal-title":"Fitoterapia"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/01480545.2019.1663865","volume":"45","author":"Han L.","year":"2022","unstructured":"Han L.; Xia Q.; Zhang L.; Zhang X.; Li X.; Zhang S.; Wang L.; Liu C.; Liu K.; Induction of developmental toxicity and cardiotoxicity in zebrafish embryos\/larvae by acetyl-11-keto-and#946;-boswellic acid (AKBA) through oxidative stress. Drug Chem Toxicol 2022,45(1),143-150","journal-title":"Drug Chem Toxicol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/ptr.6338","volume":"33","author":"Majeed M.","year":"2019","unstructured":"Majeed M.; Majeed S.; Narayanan N.K.; Nagabhushanam K.; A pilot, randomized, doubleand#8208;blind, placeboand#8208;controlled trial to assess the safety and efficacy of a novel boswellia Serrata extract in the management of osteoarthritis of the knee. Phytother Res 2019,33(5),1457-1468","journal-title":"Phytother Res"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557523666230330113611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215223\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557523666230330113611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:20:54Z","timestamp":1697631654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215223\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":106,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557523666230330113611","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}